Search Results - "Binyamin, Orli"
-
1
Mitochondrial dysfunction in preclinical genetic prion disease: A target for preventive treatment?
Published in Neurobiology of disease (01-04-2019)“…Mitochondrial malfunction is a common feature in advanced stages of neurodegenerative conditions, as is the case for the accumulation of aberrantly folded…”
Get full text
Journal Article -
2
Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice
Published in Scientific reports (05-12-2019)“…Deregulation of Cyclin-dependent kinase 5 (CDK5) by binding to the activated calpain product p25, is associated with the onset of neurodegenerative diseases,…”
Get full text
Journal Article -
3
Continues administration of Nano-PSO significantly increased survival of genetic CJD mice
Published in Neurobiology of disease (01-12-2017)“…We have shown previously that Nano-PSO, a nanodroplet formulation of pomegranate seed oil, delayed progression of neurodegeneration signs when administered for…”
Get full text
Journal Article -
4
Author Correction: Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice
Published in Scientific reports (23-01-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
5
Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD
Published in Nanomedicine (01-08-2014)“…Abstract Neurodegenerative diseases generate the accumulation of specific misfolded proteins, such as PrPSc prions or A-beta in Alzheimer's diseases, and share…”
Get full text
Journal Article -
6
PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease
Published in PloS one (2013)“…While the conversion of PrP(C) into PrP(Sc) in the transmissible form of prion disease requires a preexisting PrP(Sc) seed, in genetic prion disease…”
Get full text
Journal Article -
7
PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease
Published in PloS one (26-07-2013)“…While the conversion of PrPC into PrPSc in the transmissible form of prion disease requires a preexisting PrPSc seed, in genetic prion disease accumulation of…”
Get full text
Journal Article -
8
Correction: PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease
Published in PloS one (2015)Get full text
Journal Article -
9
Copper is toxic to PrP-ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease
Published in Neurobiology of disease (01-03-2012)“…Abstract The pathogenesis of the diverse forms of prion disease was attributed solely to the accumulation of the misfolded PrP forms, and not to the potential…”
Get full text
Journal Article -
10
Aggregation of MBP in chronic demyelination
Published in Annals of clinical and translational neurology (01-07-2015)“…Objectives Misfolding of key disease proteins to an insoluble state is associated with most neurodegenerative conditions, such as prion, Parkinson, and…”
Get full text
Journal Article -
11
Comparing anti–aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob Disease
Published in Neurobiology of aging (01-02-2022)“…•We tested aging hallmarks levels in CJD mice treated with Metformin or Nano-PSO.•Both reagents reduced aging hallmarks activities in a similar way.•Only…”
Get full text
Journal Article -
12
Delay of gCJD aggravation in sick TgMHu2ME199K mice by combining NPC transplantation and Nano-PSO administration
Published in Neurobiology of aging (01-11-2020)“…gCJD is a fatal late-onset neurodegenerative disease linked to mutations in the PRNP gene. We have previously shown that transplantation of neural precursor…”
Get full text
Journal Article -
13
Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis
Published in Journal of neuroimmunology (15-04-2024)“…The clinical effect of human Mesenchymal stem cells (hMSCs) transplanted into EAE mice/MS patients is short lived due to poor survival of the transplanted…”
Get full text
Journal Article -
14
Beneficial effects of a nano formulation of pomegranate seed oil, GranaGard, on the cognitive function of multiple sclerosis patients
Published in Multiple sclerosis and related disorders (01-09-2021)“…•No adverse events were recorded during a 3-month treatment of patients with MS with GranaGard, a brain targeting nano-formulation of PSO.•GranaGard…”
Get full text
Journal Article -
15
Genetic prion disease: no role for the immune system in disease pathogenesis?
Published in Human molecular genetics (15-04-2020)Get full text
Journal Article -
16
Corrigendum to: Genetic prion disease: no role for the immune system in disease pathogenesis?
Published in Human molecular genetics (15-04-2020)Get full text
Journal Article -
17
Autologous neural progenitor cell transplantation into newborn mice modeling for E200K genetic prion disease delays disease progression
Published in Neurobiology of aging (01-05-2018)“…TgMHu2ME199K mice, a transgenic line mimicking genetic prion disease, are born healthy and gradually deteriorate to a terminal neurological condition…”
Get full text
Journal Article -
18
QKI-V5 is downregulated in CNS inflammatory demyelinating diseases
Published in Multiple sclerosis and related disorders (01-04-2020)“…•QKI gene encodes a RNA-binding-protein that plays a central role in myelination.•Expression of QKI-V5 is decreased in the blood of NMO and MS patients.•Sera…”
Get full text
Journal Article -
19
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant
Published in International journal of nanomedicine (01-01-2015)“…Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is associated with demyelination, neurodegeneration, and…”
Get full text
Journal Article -
20
Correction: PrP.sup.ST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease
Published in PloS one (20-07-2015)Get full text
Journal Article